PATENT CLAIM ANALYSIS

Application Number: 15775312
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-12
Patent Classification: ["514", "234500"]

Abstract:
The present invention relates to a 7-azaindolin-2-one derivative or a pharmaceutically acceptable salt thereof, and the 7-azaindolin-2-one derivative or the pharmaceutically acceptable salt thereof can be favorably used as a medicinal material for inhibiting cancer growth and cancer metastasis.

Claim (Index 6):
The compound or the pharmaceutically acceptable salt thereof according to  claim 1 , wherein the pharmaceutically acceptable salt is in the form of an acid addition salt that is formed by an organic acid selected from the group consisting of oxalic acid, maleic acid, fumaric acid, malic acid, tartaric acid, citric acid and benzoic acid, or an inorganic acid selected from the group consisting of hydrochloric acid, sulfuric acid, phosphoric acid and hydrobromic acid.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 93.0
- Lexical Diversity: 1.41379
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13196391', '12451466', '12223180', '13945924', '13106076']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7971181121103267
- 35 USC 102 Novelty (BERT): 0.5179685316054582
- Combined Prediction Score: 0.7692031540598399
- Mean Citation Score: 311.092622
- Max Citation Score: 313.8167
- Similarity Product: 265.6795176997066

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test